2004
DOI: 10.1002/jnr.20208
|View full text |Cite
|
Sign up to set email alerts
|

Microarray analysis of postmortem temporal cortex from patients with schizophrenia

Abstract: To examine molecular mechanisms associated with schizophrenia this study measured expression of approximately 12,000 genes in the middle temporal gyrus from 12 subjects with schizophrenia and 14 matched normal controls. Among the most consistent changes in genes with robust expression were significant decreases in the expression of myelination-related genes MAG, PLLP (TM4SF11), PLP1, ERBB3 in subjects with schizophrenia. There was also altered expression of genes regulating neurodevelopment (TRAF4, Neurod1, hi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

16
179
1

Year Published

2005
2005
2014
2014

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 263 publications
(196 citation statements)
references
References 38 publications
16
179
1
Order By: Relevance
“…Furthermore, the circadian pattern of FBXL21 expression in the mouse suprachiasmatic nucleus (region responsible for controlling circadian rhythm) is reminiscent of the expression pattern seen for other circadian pacemaker genes such as Period 1 (PER1) (Dardente et al, 2008). Mutations in either the FBXL21 or FBXL3 genes can lead to a dysfunction of circadian rhythm oscillations and lead to significant behavioral disturbances in individuals and alterations in their sleeping patterns; moreover the absence of FBXL21 causes a short-period phenotype in both mice and cells (Hirano et al, 2013;Yoo et al, 2013 (Bromundt et al, 2011); which is further supported by a microarray study which found a significant downregulation of the circadian pacemaker gene PER1 in the postmortem temporal cortex of schizophrenia patients compared to healthy controls (Aston et al, 2004). Furthermore, an animal model study has shown dysfunction in the synchronization of circadian rhythms between brain cell networks involved in sleep-wake regulation and cognition (Dudley et al, 2003).…”
Section: Discussionmentioning
confidence: 77%
“…Furthermore, the circadian pattern of FBXL21 expression in the mouse suprachiasmatic nucleus (region responsible for controlling circadian rhythm) is reminiscent of the expression pattern seen for other circadian pacemaker genes such as Period 1 (PER1) (Dardente et al, 2008). Mutations in either the FBXL21 or FBXL3 genes can lead to a dysfunction of circadian rhythm oscillations and lead to significant behavioral disturbances in individuals and alterations in their sleeping patterns; moreover the absence of FBXL21 causes a short-period phenotype in both mice and cells (Hirano et al, 2013;Yoo et al, 2013 (Bromundt et al, 2011); which is further supported by a microarray study which found a significant downregulation of the circadian pacemaker gene PER1 in the postmortem temporal cortex of schizophrenia patients compared to healthy controls (Aston et al, 2004). Furthermore, an animal model study has shown dysfunction in the synchronization of circadian rhythms between brain cell networks involved in sleep-wake regulation and cognition (Dudley et al, 2003).…”
Section: Discussionmentioning
confidence: 77%
“…36,37,58,59 Few studies have explored global expression changes between groups of suicides and psychiatrically normal controls, some have however focused on a particular psychiatric diagnosis, such as bipolar disorder or schizophrenia, and included within these groups subjects that died by suicide. [60][61][62][63][64][65][66][67] Sibille et al 51 recently compared expression patterns in BA9 and BA47 of depressed suicides versus psychiatrically normal controls matched on the basis of sex, age, DAVID genes correspond to the total number of unique DAVID annotated genes. The percentage represents the number of differentially expressed genes belonging to a given category over the total number of DAVID annotated genes.…”
Section: Discussionmentioning
confidence: 99%
“…Increased or decreased expression of PLP1 as a result of point-mutations or duplications of the PLP1 gene cause dysmyelination of axon tracts and has been associated with pathologies such as Pelizaeus-Merzbacher disease (PMD) and X-linked spastic paraplegia type 2 (SPG2) [35,52,54]. In addition, expression of the PLP1 transcript was reported decreased in temporal cortex in schizophrenia [55]. The severity of the mutant PLP1 phenotypes has been studied extensively in human postmortem brain as well as in rodent experimental models.…”
Section: Discussionmentioning
confidence: 99%